Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04533919 · ClinicalTrials.gov registry record
Validation of Pre-clinical Nano-Based Analgesics in Cells From Human Dorsal Root Ganglia
A clinical trial of Spinal Cord Neoplasm, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 8
- Enrollment target
- 1
- Study location
NCT04533919: Recruiting study of Spinal Cord Neoplasm, sponsored by M.D. Anderson Cancer Center.
NCT04533919 is a study of Spinal Cord Neoplasm that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 8 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04533919, a study of Spinal Cord Neoplasm, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
This study investigates the pre-clinical nano-based analgesics in cells from human dorsal root ganglia (clusters of neurons). Collecting these neurons may help future research related to safe and effective pain treatment.
Conditions Studied
Interventions
- PROCEDURE Biospecimen Collection
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2020-06-16 |
| Est. Completion | 2027-04-30 |
What NCT04533919 shows while recruiting
NCT04533919 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 1 condition, with Spinal Cord Neoplasm appearing as the primary indexed condition, and to 1 intervention - of which Biospecimen Collection is the first listed.
NCT04533919 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04533919 about?
NCT04533919 is a clinical study titled "Validation of Pre-clinical Nano-Based Analgesics in Cells From Human Dorsal Root Ganglia". This study investigates the pre-clinical nano-based analgesics in cells from human dorsal root ganglia (clusters of neurons). Collecting these neurons may help future research related to safe and effective pain treatment.
What is the current status of trial NCT04533919?
This trial is currently recruiting. The enrollment target is 8 participants. The study started on 2020-06-16. Estimated completion is 2027-04-30.
What conditions does trial NCT04533919 study?
This clinical trial studies the following conditions: Spinal Cord Neoplasm.
What interventions are being tested in trial NCT04533919?
The interventions under investigation include: Biospecimen Collection (PROCEDURE).
Who is sponsoring clinical trial NCT04533919?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04533919 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI